Harriet Johansson et al., Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Research

Harriet Johansson1, Kathryn P. Gray2, Olivia Pagani3,4,5, Meredith M. Regan6, Giuse